Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 19 studies | 40% ± 14% | |
macrophage | 11 studies | 20% ± 4% | |
plasmacytoid dendritic cell | 9 studies | 33% ± 12% | |
monocyte | 8 studies | 26% ± 7% | |
classical monocyte | 7 studies | 30% ± 7% | |
regulatory T cell | 7 studies | 23% ± 6% | |
conventional dendritic cell | 5 studies | 26% ± 8% | |
myeloid cell | 5 studies | 20% ± 5% | |
epithelial cell | 5 studies | 24% ± 10% | |
B cell | 5 studies | 19% ± 3% | |
plasma cell | 4 studies | 31% ± 7% | |
secretory cell | 4 studies | 24% ± 2% | |
basal cell | 4 studies | 27% ± 9% | |
microglial cell | 4 studies | 17% ± 1% | |
dendritic cell | 4 studies | 24% ± 6% | |
goblet cell | 4 studies | 22% ± 5% | |
memory B cell | 4 studies | 18% ± 4% | |
plasmablast | 3 studies | 51% ± 22% | |
respiratory goblet cell | 3 studies | 31% ± 6% | |
squamous epithelial cell | 3 studies | 48% ± 16% | |
endothelial cell | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 4 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 94% | 1534.78 | 911 / 966 | 99% | 61.35 | 521 / 527 |
lung | 99% | 1500.48 | 574 / 578 | 94% | 45.93 | 1084 / 1155 |
esophagus | 96% | 1729.01 | 1380 / 1445 | 97% | 53.16 | 177 / 183 |
bladder | 95% | 1424.95 | 20 / 21 | 96% | 72.17 | 486 / 504 |
breast | 98% | 1009.61 | 451 / 459 | 92% | 47.75 | 1031 / 1118 |
kidney | 100% | 1620.20 | 89 / 89 | 90% | 32.81 | 809 / 901 |
stomach | 87% | 1051.13 | 312 / 359 | 98% | 59.55 | 279 / 286 |
liver | 99% | 1509.02 | 224 / 226 | 79% | 20.71 | 321 / 406 |
uterus | 85% | 485.24 | 145 / 170 | 88% | 61.30 | 406 / 459 |
ovary | 83% | 529.22 | 149 / 180 | 90% | 48.96 | 389 / 430 |
adrenal gland | 95% | 760.92 | 245 / 258 | 74% | 23.45 | 170 / 230 |
prostate | 91% | 669.96 | 223 / 245 | 53% | 12.17 | 267 / 502 |
skin | 69% | 515.82 | 1257 / 1809 | 68% | 23.84 | 321 / 472 |
thymus | 86% | 586.92 | 559 / 653 | 45% | 10.36 | 272 / 605 |
pancreas | 21% | 93.45 | 68 / 328 | 93% | 50.38 | 165 / 178 |
spleen | 100% | 3621.18 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.04 | 1 / 1 |
peripheral blood | 98% | 3981.51 | 911 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 62.47 | 44 / 45 |
adipose | 98% | 1156.91 | 1176 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 47.96 | 27 / 29 |
brain | 47% | 259.50 | 1254 / 2642 | 43% | 15.63 | 305 / 705 |
heart | 62% | 308.42 | 532 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 61% | 418.11 | 809 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 6.13 | 22 / 80 |
muscle | 7% | 28.33 | 54 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0034138 | Biological process | toll-like receptor 3 signaling pathway |
GO_0009615 | Biological process | response to virus |
GO_0051607 | Biological process | defense response to virus |
GO_0071659 | Biological process | negative regulation of IP-10 production |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0098586 | Biological process | cellular response to virus |
GO_0060700 | Biological process | regulation of ribonuclease activity |
GO_0043129 | Biological process | surfactant homeostasis |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0042742 | Biological process | defense response to bacterium |
GO_0071639 | Biological process | positive regulation of monocyte chemotactic protein-1 production |
GO_0060339 | Biological process | negative regulation of type I interferon-mediated signaling pathway |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0006006 | Biological process | glucose metabolic process |
GO_0070106 | Biological process | interleukin-27-mediated signaling pathway |
GO_0042593 | Biological process | glucose homeostasis |
GO_2000342 | Biological process | negative regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0001730 | Molecular function | 2'-5'-oligoadenylate synthetase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | OAS1 |
Protein name | 2'-5'-oligoadenylate synthetase 1 2'-5' oligoadenylate synthetase 1 p41 isoform 2'-5' oligoadenylate synthase (EC 2.7.7.84) 2'-5' oligoadenylate synthetase 1 p49 isoform 2'-5'-oligoadenylate synthase 1 ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (EC 2.7.7.84) (E18/E16) (p46/p42 OAS) Truncated 2'-5' oligoadenylate synthetase |
Synonyms | OIAS |
Description | FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response . In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication . Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. The secreted form displays antiviral effect against vesicular stomatitis virus (VSV), herpes simplex virus type 2 (HSV-2), and encephalomyocarditis virus (EMCV) and stimulates the alternative antiviral pathway independent of RNase L. .; FUNCTION: [Isoform p46]: When prenylated at C-terminal, acts as a double-stranded RNA (dsRNA) sensor specifically targeted to membranous replicative organelles in SARS coronavirus-2/SARS-CoV-2 infected cells where it binds to dsRNA structures in the SARS-CoV-2 5'-UTR and initiates a potent block to SARS-CoV-2 replication. Recognizes short stretches of dsRNA and activates RNase L. The binding is remarkably specific, with two conserved stem loops in the SARS-CoV-2 5'- untranslated region (UTR) constituting the principal viral target . The same mechanism is necessary to initiate a block to cardiovirus EMCV . .; FUNCTION: [Isoform p42]: Not prenylated at C-terminal, is diffusely localized and unable to initiate a detectable block to SARS-CoV-2 replication. . |
Accessions | ENST00000679841.1 ENST00000550883.2 ENST00000680934.1 ENST00000679767.1 S4R467 ENST00000675868.2 ENST00000452357.7 [P00973-2] H0YIB8 A0A7P0T8F9 ENST00000680522.1 ENST00000679987.1 ENST00000679467.1 A0A7P0T960 ENST00000680189.1 [P00973-1] ENST00000202917.10 [P00973-1] ENST00000540589.3 A0A7P0T9Q4 ENST00000679494.1 ENST00000680455.1 ENST00000552526.2 F8VPW7 ENST00000553185.2 C6EMZ7 B4DWE7 Q1P9K4 A0A7P0T879 A0A7P0TBG0 A7YIG8 ENST00000550689.2 A0A7P0Z4N8 ENST00000553152.2 ENST00000681700.1 A0A7P0T8E1 A0A7P0T854 ENST00000681934.1 [P00973-1] A0A7P0Z4B6 F8VUC8 ENST00000680659.1 A0A7P0TAY6 A0A7P0Z444 ENST00000680919.1 ENST00000681505.1 A0A7P0T9J4 A0A7P0TB35 S4R3A5 P00973 ENST00000679971.1 ENST00000551241.6 [P00973-4] Q3ZM02 A0A6Q8PHR1 ENST00000681228.1 ENST00000445409.7 [P00973-3] |